INTERACTION BETWEEN PIMOZIDE AND ALPHA-METHYLTYROSINE

被引：22

作者：

AHLENIUS, S ^{[1
]}

ENGEL, J ^{[1
]}

机构：

[1] UNIV GOTHENBURG,DEPT PHARMACOL,GOTHENBURG 40033,SWEDEN

来源：

JOURNAL OF PHARMACY AND PHARMACOLOGY | 1973年 / 25卷 / 02期

关键词：

D O I：

10.1111/j.2042-7158.1973.tb10615.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：172 / 174

页数：3

共 9 条

[1] BEHAVIORAL EFFECTS OF HALOPERIDOL AFTER TYROSINE HYDROXYLASE INHIBITION [J].

AHLENIUS, S ;

ENGEL, J .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1971, 15 (02) :187-&

[2] ADRENERGIC MECHANISMS [J].

ANDEN, NE ;

CARLSSON, A ;

HAGGENDAL, J .

ANNUAL REVIEW OF PHARMACOLOGY, 1969, 9 :119-+

[3] RECEPTOR ACTIVITY AND TURNOVER OF DOPAMINE AND NORADRENALINE AFTER NEUROLEPTICS [J].

ANDEN, NE ;

BUTCHER, SG ;

CORRODI, H ;

FUXE, K ;

UNGERSTEDT, U .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 11 (03) :303-+

[4] POTENTIATION OF PHENOTHIAZINES BY ALPHA-METHYLTYROSINE IN TREATMENT OF CHRONIC SCHIZOPHRENIA [J].

CARLSSON, A ;

WALINDER, J ;

ROOS, BE ;

PERSSON, T .

JOURNAL OF NEURAL TRANSMISSION, 1972, 33 (02) :83-&

[5]

Ferster CB, 1957, APPLETON CENTURY CRO

[6]

JANSSEN PAJ, 1968, ARZNEI-FORSCHUNG, V18, P261

[7] METHOD FOR DETERMINATION OF 3,4-DIHYDROXYPHENYLALANINE (DOPA) IN BRAIN [J].

KEHR, W ;

CARLSSON, A ;

LINDQVIST, M .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1972, 274 (03) :273-+

[8]

WAALKES TP, 1957, J LAB CLIN MED, V50, P733

[9]

WINER BJ, 1962, STATISTICAL PRINCIPL

← 1 →